YearStart,YearEnd,LocationAbbr,LocationDesc,DataSource,Topic,Question,Response,DataValueUnit,DataValueType,DataValue,DataValueAlt,DataValueFootnoteSymbol,DatavalueFootnote,LowConfidenceLimit,HighConfidenceLimit,StratificationCategory1,Stratification1,StratificationCategory2,Stratification2,StratificationCategory3,Stratification3,GeoLocation,ResponseID,LocationID,TopicID,QuestionID,DataValueTypeID,StratificationCategoryID1,StratificationID1,StratificationCategoryID2,StratificationID2,StratificationCategoryID3,StratificationID3
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.4,50.4,,,41.5,59.2,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.8,54.8,,,46.7,62.5,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.2,41.2,,,34.4,48.2,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.1,44.1,,,35.0,53.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.0,49.0,,,39.9,58.1,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.1,29.1,,,16.5,46.1,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.3,34.3,,,26.0,43.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.9,45.9,,,38.5,53.6,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.9,45.9,,,36.6,55.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.4,40.4,,,27.8,54.5,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.8,37.8,,,29.0,47.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.3,26.3,,,15.7,40.5,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.0,39.0,,,27.2,52.3,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.7,39.7,,,32.3,47.7,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.7,43.7,,,35.0,52.8,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.1,38.1,,,26.1,51.8,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.0,40.0,,,31.3,49.3,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.8,48.8,,,39.4,58.3,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.3,38.3,,,24.9,53.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.8,39.8,,,26.6,54.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.7,36.7,,,29.5,44.6,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.1,46.1,,,38.4,54.0,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.0,42.0,,,26.1,59.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.6,40.6,,,27.5,55.3,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.5,36.5,,,29.1,44.6,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.0,38.0,,,29.0,47.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.4,37.4,,,26.1,50.3,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,27.9,46.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,26.8,46.1,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.3,34.3,,,26.2,43.5,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.6,37.6,,,29.8,46.1,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.1,36.1,,,30.6,41.9,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.2,36.2,,,30.5,42.3,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.9,36.9,,,32.1,41.9,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,32.0,41.5,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.1,38.1,,,30.1,46.9,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.9,38.9,,,32.7,45.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.7,34.7,,,25.8,44.8,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.7,40.7,,,34.7,47.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.7,37.7,,,30.0,46.0,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.5,32.5,,,23.1,43.5,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.2,37.2,,,28.2,47.1,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.8,46.8,,,38.1,55.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.8,33.8,,,26.1,42.4,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,27.0,45.9,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.7,52.7,,,43.6,61.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.3,33.3,,,25.8,41.6,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.2,40.2,,,34.6,46.2,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.1,44.1,,,36.6,52.0,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.1,39.1,,,33.7,44.8,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.7,42.7,,,35.5,50.2,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.5,53.5,,,49.2,57.7,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.5,46.5,,,38.3,55.0,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.4,55.4,,,50.0,60.6,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.6,54.6,,,49.3,59.7,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.0,42.0,,,33.0,51.6,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,59.6,59.6,,,54.4,64.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.7,52.7,,,48.5,56.9,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.7,49.7,,,42.7,56.8,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,58.3,58.3,,,53.1,63.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.3,49.3,,,42.3,56.2,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.3,53.3,,,47.8,58.8,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,58.4,58.4,,,51.5,65.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.4,52.4,,,47.1,57.6,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.4,36.4,,,27.6,46.2,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,59.9,59.9,,,52.7,66.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.0,52.0,,,42.2,61.6,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.1,35.1,,,25.9,45.4,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.0,54.0,,,47.4,60.4,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.6,55.6,,,38.4,71.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.9,50.9,,,42.5,59.3,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.1,54.1,,,47.6,60.6,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,53.5,53.5,,,38.4,68.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,72.2,72.2,,,59.4,82.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.1,50.1,,,41.4,58.8,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.9,52.9,,,42.4,63.0,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,53.5,53.5,,,42.9,63.9,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.3,39.3,,,28.1,51.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.5,43.5,,,30.4,57.6,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.0,36.0,,,25.8,47.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.3,44.3,,,29.6,60.1,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,75.9,75.9,,,65.5,84.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.9,52.9,,,41.6,63.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.7,48.7,,,40.0,57.4,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.7,36.7,,,23.1,52.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.7,52.7,,,42.0,63.2,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.7,47.7,,,38.8,56.7,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.5,38.5,,,24.7,54.5,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.1,38.1,,,23.6,55.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.4,38.4,,,23.7,55.5,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.0,54.0,,,43.9,63.8,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,51.4,51.4,,,38.9,63.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,25.8,25.8,,,17.5,36.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.9,38.9,,,33.1,45.1,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.4,47.4,,,39.4,55.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.3,35.3,,,24.1,48.4,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.8,42.8,,,32.6,53.8,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.5,46.5,,,38.0,55.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.5,28.5,,,16.2,45.1,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.4,38.4,,,31.4,46.0,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.5,37.5,,,31.4,44.0,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.1,39.1,,,32.3,46.4,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.7,29.7,,,16.7,47.2,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.3,29.3,,,20.8,39.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.0,41.0,,,30.0,53.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.3,40.3,,,33.2,47.8,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.4,47.4,,,33.4,61.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.6,43.6,,,37.4,49.9,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.6,41.6,,,30.5,53.5,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.1,39.1,,,27.2,52.4,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,51.4,51.4,,,40.5,62.2,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.1,50.1,,,34.9,65.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.5,46.5,,,35.7,57.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.7,49.7,,,38.7,60.6,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.7,39.7,,,28.0,52.6,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.5,39.5,,,32.7,46.8,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.4,43.4,,,37.3,49.6,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.5,43.5,,,33.4,54.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.8,49.8,,,44.4,55.2,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,43.8,55.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,42.8,56.9,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.9,49.9,,,44.4,55.4,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.4,49.4,,,43.4,55.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.9,48.9,,,40.5,57.4,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.0,50.0,,,41.4,58.6,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.0,49.0,,,42.1,55.8,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.9,32.9,,,24.2,43.0,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,24.4,42.9,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.0,40.0,,,33.8,46.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.7,37.7,,,31.3,44.6,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.1,36.1,,,30.8,41.9,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.1,36.1,,,30.7,41.7,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.5,40.5,,,34.4,47.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.9,37.9,,,31.3,45.0,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.0,45.0,,,31.3,59.6,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.6,45.6,,,34.1,57.5,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.2,49.2,,,37.9,60.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.0,45.0,,,35.8,54.5,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.3,44.3,,,35.8,53.2,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.0,50.0,,,38.5,61.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.2,45.2,,,33.6,57.4,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.7,43.7,,,29.4,59.1,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.4,43.4,,,38.0,48.9,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.8,43.8,,,38.4,49.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.9,37.9,,,30.4,46.1,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.1,41.1,,,36.6,45.8,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.8,36.8,,,28.8,45.6,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.6,30.6,,,19.7,44.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.6,40.6,,,36.2,45.1,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.1,42.1,,,36.9,47.6,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.4,42.4,,,37.2,47.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.8,33.8,,,22.0,48.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.8,48.8,,,44.9,52.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.1,38.1,,,32.8,43.7,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.0,43.0,,,30.5,56.4,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.4,46.4,,,42.9,49.9,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.8,49.8,,,45.5,54.1,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.4,37.4,,,24.4,52.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.3,45.3,,,42.0,48.7,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.5,51.5,,,47.1,55.9,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.6,36.6,,,23.5,52.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.8,46.8,,,43.1,50.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.6,37.6,,,32.2,43.2,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.8,46.8,,,33.7,60.4,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.5,41.5,,,34.0,49.4,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.7,38.7,,,32.4,45.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.9,29.9,,,21.8,39.6,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.9,37.9,,,31.3,45.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.5,30.5,,,22.1,40.4,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.8,36.8,,,30.8,43.3,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.7,37.7,,,31.9,43.8,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.4,40.4,,,32.7,48.6,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.5,35.5,,,27.7,44.1,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.0,38.0,,,28.9,48.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.2,34.2,,,27.8,41.2,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.9,34.9,,,28.4,42.0,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.2,40.2,,,31.8,49.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,22.9,46.6,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.9,34.9,,,27.2,43.5,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.9,28.9,,,19.4,40.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.5,33.5,,,22.7,46.3,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.1,28.1,,,18.1,40.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.6,53.6,,,47.2,59.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.6,39.6,,,32.2,47.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,61.6,61.6,,,55.1,67.7,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.5,44.5,,,36.1,53.2,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.2,46.2,,,40.6,52.0,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.6,46.6,,,41.9,51.3,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,61.4,61.4,,,56.2,66.3,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,23.7,23.7,,,13.6,38.0,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,61.1,61.1,,,53.1,68.7,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.5,45.5,,,40.7,50.4,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,60.6,60.6,,,54.6,66.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.6,50.6,,,37.8,63.3,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,62.9,62.9,,,56.9,68.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.7,26.7,,,15.1,42.6,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,59.7,59.7,,,54.6,64.6,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.2,40.2,,,32.2,48.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.4,47.4,,,41.8,53.1,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.3,51.3,,,37.8,64.5,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,59.1,59.1,,,52.8,65.1,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,61.0,61.0,,,52.6,68.7,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.3,52.3,,,45.5,59.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.5,44.5,,,36.2,53.1,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.8,50.8,,,44.6,57.0,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.6,45.6,,,40.5,50.6,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.8,46.8,,,42.0,51.7,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.7,51.7,,,45.9,57.4,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.2,34.2,,,26.3,43.1,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.3,48.3,,,43.3,53.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.7,46.7,,,41.4,52.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.6,36.6,,,28.5,45.5,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.4,49.4,,,43.8,55.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.0,40.0,,,31.8,48.8,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.1,40.1,,,32.5,48.2,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.7,34.7,,,24.2,46.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.0,45.0,,,40.2,49.9,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.2,30.2,,,20.1,42.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.7,47.7,,,41.9,53.5,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.5,48.5,,,42.9,54.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.1,46.1,,,40.3,52.1,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.9,43.9,,,39.3,48.7,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.8,48.8,,,42.1,55.5,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.2,53.2,,,49.2,57.1,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.7,49.7,,,35.8,63.6,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.7,55.7,,,51.2,60.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.4,55.4,,,50.4,60.2,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.9,52.9,,,48.9,56.9,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.3,55.3,,,50.3,60.2,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.6,48.6,,,32.5,65.0,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.0,49.0,,,42.4,55.7,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,56.1,56.1,,,51.8,60.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.6,36.6,,,23.4,52.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.4,46.4,,,40.0,52.9,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.1,37.1,,,23.7,52.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.8,46.8,,,40.8,52.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.9,39.9,,,31.4,49.1,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.1,47.1,,,41.1,53.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.5,38.5,,,30.2,47.6,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.4,43.4,,,38.3,48.8,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.1,46.1,,,39.8,52.6,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.4,43.4,,,38.3,48.8,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.2,37.2,,,29.3,45.9,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,26.5,40.3,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.4,27.4,,,18.4,38.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.7,40.7,,,31.5,50.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.0,36.0,,,28.1,44.8,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.2,33.2,,,26.6,40.7,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.8,27.8,,,17.5,41.0,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.9,39.9,,,31.0,49.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.5,30.5,,,19.3,44.7,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.3,29.3,,,19.7,41.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.5,45.5,,,37.9,53.2,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.9,41.9,,,35.9,48.0,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.9,40.9,,,34.6,47.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.5,44.5,,,37.0,52.4,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.4,41.4,,,34.9,48.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.6,41.6,,,35.8,47.7,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.8,34.8,,,26.0,44.9,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.2,35.2,,,26.6,44.9,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,40.4,59.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.7,45.7,,,37.4,54.2,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.7,29.7,,,19.1,43.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.9,43.9,,,37.1,51.0,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.8,40.8,,,29.3,53.3,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.2,39.2,,,27.8,51.9,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.2,45.2,,,37.0,53.5,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.8,30.8,,,19.8,44.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.8,49.8,,,40.6,59.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.5,43.5,,,36.7,50.6,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.2,45.2,,,34.9,55.9,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.7,55.7,,,46.0,65.1,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,51.5,51.5,,,44.7,58.3,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.0,52.0,,,44.0,59.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.2,52.2,,,44.5,59.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.3,47.3,,,37.4,57.4,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,42.4,57.1,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.0,54.0,,,43.7,63.9,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.2,45.2,,,33.7,57.1,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.2,51.2,,,44.4,57.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,59.0,59.0,,,52.7,65.0,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.0,54.0,,,48.9,58.9,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.1,54.1,,,48.7,59.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.6,45.6,,,34.7,57.0,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.9,49.9,,,43.0,56.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.1,54.1,,,49.1,59.1,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,59.4,59.4,,,53.2,65.4,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.0,50.0,,,43.4,56.6,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.1,44.1,,,36.4,52.2,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.2,44.2,,,35.8,52.9,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,53.3,53.3,,,45.6,60.9,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.4,54.4,,,48.9,59.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.4,51.4,,,44.9,57.9,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.1,52.1,,,45.5,58.5,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,56.3,56.3,,,47.5,64.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.4,51.4,,,43.3,59.4,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.5,55.5,,,45.9,64.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.7,44.7,,,33.7,56.2,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.0,52.0,,,45.7,58.2,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,51.1,51.1,,,43.4,58.6,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.7,45.7,,,35.9,55.8,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.8,50.8,,,38.9,62.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.8,53.8,,,43.1,64.2,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.9,52.9,,,39.7,65.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.4,54.4,,,44.1,64.3,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.2,40.2,,,31.7,49.4,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.4,44.4,,,38.3,50.6,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.0,52.0,,,42.2,61.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.3,44.3,,,38.1,50.7,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.7,52.7,,,41.8,63.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.7,49.7,,,42.3,57.1,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.4,49.4,,,41.8,57.0,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.1,33.1,,,23.4,44.5,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.5,37.5,,,28.8,47.0,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.3,33.3,,,23.3,44.9,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.2,38.2,,,26.3,51.7,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.7,35.7,,,22.9,50.9,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.6,38.6,,,28.9,49.4,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.7,39.7,,,27.8,53.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.3,39.3,,,23.9,57.2,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.4,43.4,,,30.5,57.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.5,36.5,,,27.0,47.3,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.0,35.0,,,24.2,47.6,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.8,47.8,,,43.8,51.9,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.3,42.3,,,35.3,49.6,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.1,45.1,,,41.7,48.4,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.2,52.2,,,34.2,69.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.6,33.6,,,26.1,42.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.8,48.8,,,32.8,65.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.9,47.9,,,43.4,52.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.7,40.7,,,35.2,46.4,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,28.7,71.0,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.4,31.4,,,24.2,39.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.7,48.7,,,44.3,53.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.6,47.6,,,32.5,63.3,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.7,40.7,,,35.0,46.6,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.3,46.3,,,42.1,50.5,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.4,43.4,,,36.2,51.0,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.0,44.0,,,40.6,47.4,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.4,52.4,,,37.8,66.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.6,44.6,,,39.2,50.2,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.0,44.0,,,39.5,48.5,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.8,52.8,,,37.6,67.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.9,45.9,,,40.5,51.4,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.2,38.2,,,30.9,46.1,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.6,33.6,,,19.5,51.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.7,39.7,,,32.1,47.9,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.0,42.0,,,37.0,47.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.8,33.8,,,18.5,53.3,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.6,42.6,,,38.2,47.2,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.5,43.5,,,38.6,48.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.5,34.5,,,29.3,40.0,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.1,41.1,,,34.6,48.0,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,24.1,24.1,,,16.8,33.2,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.9,35.9,,,29.4,42.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.1,37.1,,,30.2,44.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,23.8,23.8,,,16.7,32.8,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.1,35.1,,,29.7,40.9,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.8,41.8,,,34.8,49.1,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,53.4,53.4,,,46.9,59.6,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.1,52.1,,,45.8,58.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.2,55.2,,,48.4,61.9,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,44.4,55.3,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.6,38.6,,,30.2,47.7,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.1,48.1,,,42.8,53.4,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.4,39.4,,,30.9,48.6,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.2,49.2,,,43.3,55.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.8,47.8,,,40.6,55.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.9,45.9,,,40.3,51.7,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.5,43.5,,,34.6,52.9,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.0,48.0,,,40.6,55.4,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.9,30.9,,,21.7,42.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.2,48.2,,,40.7,55.8,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,22.3,47.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.5,46.5,,,40.7,52.4,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.0,47.0,,,39.9,54.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.7,41.7,,,33.3,50.6,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.3,51.3,,,44.9,57.7,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,56.5,56.5,,,48.9,63.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.2,46.2,,,32.2,60.7,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.3,50.3,,,44.1,56.5,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.1,55.1,,,47.8,62.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.1,31.1,,,21.9,42.2,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.2,52.2,,,40.6,63.6,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,51.9,51.9,,,41.3,62.3,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.0,46.0,,,32.2,60.4,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.6,31.6,,,21.3,44.0,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.6,28.6,,,21.9,36.5,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.6,29.6,,,23.6,36.4,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.7,50.7,,,43.4,58.1,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.6,49.6,,,42.2,57.1,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.0,29.0,,,21.8,37.5,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.8,29.8,,,23.9,36.4,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.7,29.7,,,23.7,36.5,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.7,29.7,,,23.8,36.2,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.9,40.9,,,34.9,47.1,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.8,45.8,,,37.9,53.9,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.3,44.3,,,36.8,52.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.3,29.3,,,21.2,39.1,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.0,47.0,,,39.9,54.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.1,28.1,,,19.6,38.5,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.5,31.5,,,20.8,44.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.0,40.0,,,34.0,46.3,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.3,39.3,,,28.6,51.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.0,48.0,,,40.6,55.6,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,57.0,57.0,,,45.9,67.4,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,57.7,57.7,,,46.2,68.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,61.9,61.9,,,42.6,78.1,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,66.5,66.5,,,46.5,82.0,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,58.2,58.2,,,45.3,70.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,57.6,57.6,,,45.7,68.7,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,60.3,60.3,,,44.1,74.5,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.4,54.4,,,43.4,65.1,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.4,54.4,,,41.3,66.9,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,56.6,56.6,,,46.8,65.9,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.7,44.7,,,36.8,52.9,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.1,45.1,,,38.4,52.0,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.2,50.2,,,42.8,57.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.0,45.0,,,32.8,57.7,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.1,45.1,,,38.3,52.0,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.0,51.0,,,43.5,58.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.8,45.8,,,33.7,58.3,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.8,44.8,,,37.1,52.8,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.3,34.3,,,22.7,48.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.5,40.5,,,34.4,47.0,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.6,45.6,,,37.3,54.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.3,47.3,,,39.3,55.6,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.8,37.8,,,25.9,51.3,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.4,45.4,,,37.3,53.8,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.7,42.7,,,36.4,49.2,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.2,36.2,,,25.5,48.4,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.0,33.0,,,24.3,43.0,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.5,37.5,,,22.8,54.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.2,43.2,,,34.4,52.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.7,32.7,,,23.8,43.2,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.7,44.7,**,US estimate/number is based on fewer than 50 states and the District of Columbia,43.4,47.7,Overall,Overall,,,,,,,59,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.0,47.0,,,42.7,51.4,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.3,49.3,,,43.3,55.4,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.0,40.0,**,US estimate/number is based on fewer than 50 states and the District of Columbia,38.4,44.2,Gender,Male,,,,,,,59,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.9,47.9,**,US estimate/number is based on fewer than 50 states and the District of Columbia,45.7,50.8,Gender,Female,,,,,,,59,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.2,48.2,,,43.4,53.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.3,42.3,,,35.7,49.2,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.4,36.4,,,24.6,50.1,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.0,47.0,,,42.0,52.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.2,46.2,**,US estimate/number is based on fewer than 50 states and the District of Columbia,45.2,49.8,Gender,Female,,,,,,,59,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.8,34.8,,,23.5,48.2,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.0,46.0,,,41.5,50.6,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.2,40.2,**,US estimate/number is based on fewer than 50 states and the District of Columbia,38.1,44.1,Gender,Male,,,,,,,59,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.2,50.2,,,44.5,55.9,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.1,45.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,43.6,48.7,Overall,Overall,,,,,,,59,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.5,46.5,,,37.4,55.7,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.5,55.5,,,49.1,61.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.5,48.5,,,43.2,53.9,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.9,55.9,,,49.4,62.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.8,49.8,,,43.4,56.3,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.3,37.3,,,26.7,49.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.8,50.8,,,44.6,57.1,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.9,40.9,,,30.4,52.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.4,45.4,,,36.6,54.6,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.5,49.5,,,44.3,54.7,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.3,50.3,,,43.7,56.8,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.8,51.8,,,43.4,60.1,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.1,49.1,,,42.6,55.7,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.5,49.5,,,41.5,57.5,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.6,49.6,,,42.7,56.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.8,47.8,,,37.4,58.4,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.0,51.0,,,44.2,57.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.3,46.3,,,36.5,56.5,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.3,49.3,,,36.4,62.2,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.3,40.3,,,33.7,47.1,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.0,49.0,,,44.7,53.4,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.0,54.0,,,48.5,59.4,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.4,55.4,,,49.8,60.9,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,62.7,62.7,,,48.7,74.9,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.9,51.9,,,38.2,65.5,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.1,40.1,,,33.4,47.1,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.3,48.3,,,43.4,53.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.0,48.0,,,42.7,53.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,60.0,60.0,,,43.4,74.5,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.6,49.6,,,45.2,54.1,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.6,50.6,,,43.2,57.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.1,46.1,,,34.4,58.3,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.0,53.0,,,44.3,61.6,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.9,52.9,,,45.8,59.9,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,56.4,56.4,,,48.0,64.5,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.6,51.6,,,44.7,58.4,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.7,48.7,,,37.7,59.8,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.3,50.3,,,42.8,57.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.6,39.6,,,34.2,45.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.6,32.6,,,25.0,41.4,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.8,44.8,,,38.6,51.0,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.7,38.7,,,33.7,43.9,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.4,40.4,,,35.5,45.5,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.3,41.3,,,36.1,46.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.6,42.6,,,36.3,49.3,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.3,31.3,,,23.9,39.8,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.2,33.2,,,24.3,43.4,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.0,32.0,,,24.6,40.4,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.2,34.2,,,25.8,43.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,23.3,23.3,,,14.7,34.9,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.5,35.5,,,27.2,44.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.5,25.5,,,15.2,39.5,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.3,37.3,,,27.2,48.7,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.8,29.8,,,23.0,37.8,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,OVERALL,OVR,,,,
